Scientific Letter
Combined therapy of tocilizumab and corticosteroids in severe SARS-CoV-2 disease
Terapia combinada de tocilizumab y corticoides en la enfermedad grave por SARS-CoV-2
A. González-Castro
, E. Cuenca Fito, A. Fernandez, P. Escudero Acha, J.C. Rodríguez Borregán, Y. Peñasco
Autor para correspondencia
Servicio de Medicina Intensiva, Hospital Universitario Marqués de Valdecilla, Santander, Spain
Leído
5658
Vecesse ha leído el artículo
1706
Total PDF
3952
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 11 | 117 | 37 | 154 |
| 2025 10 | 14 | 63 | 77 |
| 2025 9 | 0 | 48 | 48 |
| 2025 8 | 0 | 45 | 45 |
| 2025 7 | 0 | 42 | 42 |
| 2025 6 | 3 | 38 | 41 |
| 2025 5 | 148 | 48 | 196 |
| 2025 4 | 115 | 46 | 161 |
| 2025 3 | 112 | 40 | 152 |
| 2025 2 | 113 | 31 | 144 |
| 2025 1 | 87 | 48 | 135 |
| 2024 12 | 85 | 37 | 122 |
| 2024 11 | 83 | 57 | 140 |
| 2024 10 | 79 | 61 | 140 |
| 2024 9 | 71 | 35 | 106 |
| 2024 8 | 95 | 54 | 149 |
| 2024 7 | 93 | 34 | 127 |
| 2024 6 | 89 | 49 | 138 |
| 2024 5 | 71 | 43 | 114 |
| 2024 4 | 60 | 35 | 95 |
| 2024 3 | 58 | 37 | 95 |
| 2024 2 | 49 | 40 | 89 |
| 2024 1 | 60 | 34 | 94 |
| 2023 12 | 72 | 48 | 120 |
| 2023 11 | 85 | 63 | 148 |
| 2023 10 | 75 | 59 | 134 |
| 2023 9 | 76 | 54 | 130 |
| 2023 8 | 53 | 19 | 72 |
| 2023 7 | 65 | 35 | 100 |
| 2023 6 | 58 | 31 | 89 |
| 2023 5 | 90 | 36 | 126 |
| 2023 4 | 103 | 31 | 134 |
| 2023 3 | 140 | 36 | 176 |
| 2023 2 | 86 | 29 | 115 |
| 2022 1 | 74 | 35 | 109 |
| 2022 12 | 113 | 47 | 160 |
| 2022 11 | 93 | 37 | 130 |
| 2022 10 | 105 | 44 | 149 |
| 2022 9 | 107 | 47 | 154 |
| 2022 8 | 113 | 42 | 155 |
| 2022 7 | 23 | 1 | 24 |
| 2022 6 | 37 | 0 | 37 |
| 2022 5 | 68 | 4 | 72 |
| 2022 4 | 276 | 0 | 276 |
| 2022 3 | 438 | 6 | 444 |
Mostrar todo
